Harold E. Varmus, MD, has been nominated by President Barack Obama to serve as the director of the NCI.
Harold E. Varmus, MD, has been nominated by President Barack Obama to serve as the director of the NCI. Dr. Varmus most recently served as president and CEO of Memorial Sloan-Kettering Cancer Center in New York. Dr. Varmus, J. Michael Bishop, MD, and colleagues won the 1989 Nobel Prize for Physiology or Medicine when they demonstrated the cellular origins of the oncogene of a chicken retrovirus. This led to the isolation of cellular genes that control growth and development and are frequently mutated in human cancer. The NCI directorship will be Dr. Varmus' second go-round heading up a federal institution: He served as director of the NIH from 1993 to 1999.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.